Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 138

1.

Undetected multidrug-resistant tuberculosis amplified by first-line therapy in mixed infection.

Hingley-Wilson SM, Casey R, Connell D, Bremang S, Evans JT, Hawkey PM, Smith GE, Jepson A, Philip S, Kon OM, Lalvani A.

Emerg Infect Dis. 2013 Jul;19(7):1138-41. doi: 10.3201/1907.130313.

2.

Microarray analysis of efflux pump genes in multidrug-resistant Mycobacterium tuberculosis during stress induced by common anti-tuberculous drugs.

Gupta AK, Katoch VM, Chauhan DS, Sharma R, Singh M, Venkatesan K, Sharma VD.

Microb Drug Resist. 2010 Mar;16(1):21-8. doi: 10.1089/mdr.2009.0054.

PMID:
20001742
3.

Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Park SK, Kim JH, Kang H, Cho JS, Smego RA Jr.

Int J Infect Dis. 2009 Mar;13(2):170-5. doi: 10.1016/j.ijid.2008.06.001. Epub 2008 Sep 2.

4.

The impact of expanded testing for multidrug resistant tuberculosis using genotype [correction of geontype] MTBDRplus in South Africa: an observational cohort study.

Hanrahan CF, Dorman SE, Erasmus L, Koornhof H, Coetzee G, Golub JE.

PLoS One. 2012;7(11):e49898. doi: 10.1371/journal.pone.0049898. Epub 2012 Nov 30. Erratum in: PLoS One. 2013;8(6). doi: 10.1371/annotation/47420ec0-db00-4994-a0de-86b5e5d713f4.

5.

Increasing resistance of M. tuberculosis to anti-TB drugs in Saudi Arabia.

Khan MY, Kinsara AJ, Osoba AO, Wali S, Samman Y, Memish Z.

Int J Antimicrob Agents. 2001 May;17(5):415-8.

PMID:
11337231
6.

Genotypes and drug susceptibility of Mycobacterium tuberculosis Isolates in Shihezi, Xinjiang Province, China.

Zhang J, Mi L, Wang Y, Liu P, Liang H, Huang Y, Lv B, Yuan L.

BMC Res Notes. 2012 Jun 19;5:309. doi: 10.1186/1756-0500-5-309.

7.

Resistance patterns of Mycobacterium tuberculosis isolates from pulmonary tuberculosis patients in Nairobi.

Ndung'u PW, Kariuki S, Ng'ang'a Z, Revathi G.

J Infect Dev Ctries. 2012 Jan 12;6(1):33-9.

8.

Tuberculosis Treatment Outcome and Drug Resistance in Lambaréné, Gabon: A Prospective Cohort Study.

Bélard S, Remppis J, Bootsma S, Janssen S, Kombila DU, Beyeme JO, Rossatanga EG, Kokou C, Osbak KK, Obiang Mba RM, Kaba HM, Traoré AN, Ehrhardt J, Bache EB, Flamen A, Rüsch-Gerdes S, Frank M, Adegnika AA, Lell B, Niemann S, Kremsner PG, Loembé MM, Alabi AS, Grobusch MP.

Am J Trop Med Hyg. 2016 Aug 3;95(2):472-80. doi: 10.4269/ajtmh.15-0668. Epub 2016 Jun 27.

PMID:
27352879
9.

Description of primary multidrug-resistant tuberculous meningitis in an Italian child.

Mauro MV, Cavalcanti P, Ledonne R, Giraldi C, Sperlì D.

Microb Drug Resist. 2012 Feb;18(1):71-3. doi: 10.1089/mdr.2011.0045. Epub 2011 Jun 28.

PMID:
21711151
10.

Clonal expansion of Mycobacterium tuberculosis isolates and coexisting drug resistance in patients newly diagnosed with pulmonary tuberculosis in Hanoi, Vietnam.

Hung NV, Ando H, Thuy TT, Kuwahara T, Hang NT, Sakurada S, Thuong PH, Lien LT, Keicho N.

BMC Res Notes. 2013 Nov 5;6:444. doi: 10.1186/1756-0500-6-444.

11.

Primary multidrug-resistant Mycobacterium tuberculosis in 2 regions, Eastern Siberia, Russian Federation.

Zhdanova S, Heysell SK, Ogarkov O, Boyarinova G, Alexeeva G, Pholwat S, Zorkaltseva E, Houpt ER, Savilov E.

Emerg Infect Dis. 2013 Oct;19(10):1649-52. doi: 10.3201/eid1910.121108.

12.

[Molecular diagnosis of Mycobacterium tuberculosis complex resistant to isoniazid and rifampicin in Burkina Faso].

Désire I, Cyrille B, Florencia D, Souba D, Albert Y, Valerie BJ, Rebecca C, Charlemagne G, Tamboura D, Rémy M, Virginio P, Simplice KD, Martial O, Jacques S.

Pan Afr Med J. 2015 May 29;21:73. doi: 10.11604/pamj.2015.21.73.5494. eCollection 2015. French. No abstract available.

13.

Epidemiology of antituberculosis drug resistance in Saudi Arabia: findings of the first national survey.

Al-Hajoj S, Varghese B, Shoukri MM, Al-Omari R, Al-Herbwai M, Alrabiah F, Alrajhi AA, Abuljadayel N, Al-Thawadi S, Zumla A, Zignol M, Raviglione MC, Memish Z.

Antimicrob Agents Chemother. 2013 May;57(5):2161-6. doi: 10.1128/AAC.02403-12. Epub 2013 Mar 4.

14.

[Reasons for drug-resistant tuberculosis emergence].

Tu DH.

Zhonghua Jie He He Hu Xi Za Zhi. 2007 Jun;30(6):403-5. Chinese. No abstract available.

PMID:
17673006
15.

Use of multiplex allele-specific polymerase chain reaction (MAS-PCR) to detect multidrug-resistant tuberculosis in Panama.

Chia BS, Lanzas F, Rifat D, Herrera A, Kim EY, Sailer C, Torres-Chavolla E, Narayanaswamy P, Einarsson V, Bravo J, Pascale JM, Ioerger TR, Sacchettini JC, Karakousis PC.

PLoS One. 2012;7(7):e40456. doi: 10.1371/journal.pone.0040456. Epub 2012 Jul 6.

16.

[Resistant tuberculosis: a molecular review].

Rossetti ML, Valim AR, Silva MS, Rodrigues VS.

Rev Saude Publica. 2002 Aug;36(4):525-32. Review. Portuguese.

17.
18.

Evaluation of GenoType MTBDRplus for the rapid detection of drug-resistant tuberculosis in Ghana.

Asante-Poku A, Otchere ID, Danso E, Mensah DD, Bonsu F, Gagneux S, Yeboah-Manu D.

Int J Tuberc Lung Dis. 2015 Aug;19(8):954-9. doi: 10.5588/ijtld.14.0864.

19.

Concomitant multidrug-resistant pulmonary tuberculosis and susceptible tuberculous meningitis.

Bernard C, Brossier F, Fréchet-Jachym M, Morand PC, Coignard S, Aslangul E, Aubry A, Jarlier V, Sougakoff W, Veziris N.

Emerg Infect Dis. 2014 Mar;20(3):506-7. doi: 10.3201/eid2003.131205. No abstract available.

20.

Mycobacterium tuberculosis complex strains and drug susceptibility in a cattle-rearing region of Cameroon.

Kuaban C, Um Boock A, Noeske J, Bekang F, Eyangoh S.

Int J Tuberc Lung Dis. 2014 Jan;18(1):34-8. doi: 10.5588/ijtld.13.0333.

PMID:
24365549

Supplemental Content

Support Center